
StudyFinder
EX-VIVO TARGETED TREATMENT OF CANCEROUS EXTIRPATED PROSTATE TISSUE
.png)
Status: Recruiting
This study focuses on testing new treatments on prostate tissue that has been removed during surgery. All testing is done in a lab setting to help develop and improve potential treatment options.
Sex: Male
Age Group: 18 years and over
Inclusion Criteria:
• age 18 or older
• scheduled to undergo a radical prostatectomy
• able to understand and provide informed consent
Conditions:
Cancer, Kidney, Prostate & Urinary
Keywords:
Clinics and Surgery Center (CSC), Prostate Cancer
Study Contact: Tracy Daye-Groves - tmgroves@umn.edu
Principal Investigator: Christopher Warlick, MD
IRB Number: STUDY00010808